Quorips, a Tokyo venture aiming to commercialize allogenic iPS cell derived cardiomyocyte sheets, obtained about 1 billion yen venture capital from Daiichi Sankyo, Terumo, and Kyoto University Innovation Capital.
Terumo press release, July 11, 2018
Quorips, a Tokyo venture aiming to commercialize allogenic iPS cell derived cardiomyocyte sheets, obtained about 1 billion yen venture capital from Daiichi Sankyo, Terumo, and Kyoto University Innovation Capital.
Terumo press release, July 11, 2018
This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.
Accept or Deny